Morabito F, Tripepi G, Del Poeta G, Mauro FR, et al. Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Am J Hematol 2021;96:E168-E171.
PMID: 33580969